Variant report

Variant	rs1168975
Chromosome Location	chr2:96814075-96814076
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CREB1	chr2:96813989-96814922	GM12878	blood:	n/a	n/a
2	EP300	chr2:96814059-96814564	SK-N-SH_RA	brain:	n/a	n/a
3	EGR1	chr2:96814073-96814574	H1-hESC	embryonic stem cell:	n/a	chr2:96814268-96814281 chr2:96814453-96814463 chr2:96814536-96814546 chr2:96814531-96814544 chr2:96814527-96814549 chr2:96814534-96814544
4	KAP1	chr2:96813919-96814548	U2OS	brain:	n/a	chr2:96814389-96814398
5	CEBPB	chr2:96814061-96814742	Hela-S3	cervix:	n/a	n/a
6	JUN	chr2:96814045-96814947	K562	blood:	n/a	chr2:96814391-96814399 chr2:96814388-96814396
7	ESRRA	chr2:96807401-96815327	GM12878	blood:	n/a	chr2:96814549-96814568 chr2:96812831-96812844 chr2:96814530-96814543 chr2:96808836-96808848 chr2:96812889-96812902
8	RCOR1	chr2:96814022-96814683	GM12878	blood:	n/a	n/a
9	TBP	chr2:96814027-96814622	GM12878	blood:	n/a	n/a
10	TBP	chr2:96814031-96814442	Hela-S3	cervix:	n/a	n/a
11	POLR2A	chr2:96813778-96814538	GM12892	blood:	n/a	n/a
12	SMARCC1	chr2:96813402-96815037	Hela-S3	cervix:	n/a	chr2:96814390-96814399
13	CREB1	chr2:96814009-96814928	H1-hESC	embryonic stem cell:	n/a	n/a
14	ELF1	chr2:96814062-96814976	GM12878	blood:	n/a	n/a
15	MAZ	chr2:96814064-96814974	Hela-S3	cervix:	n/a	chr2:96814921-96814930 chr2:96814534-96814544
16	EP300	chr2:96813919-96814831	SK-N-SH	brain:	n/a	chr2:96813968-96813982
17	MAZ	chr2:96813396-96814820	IMR90	lung:	n/a	chr2:96814534-96814544
18	POLR2A	chr2:96813607-96814710	GM19193	blood:	n/a	n/a
19	POLR2A	chr2:96813354-96814609	GM12878	blood:	n/a	n/a
20	CREB1	chr2:96814066-96814886	H1-hESC	embryonic stem cell:	n/a	n/a
21	EP300	chr2:96811760-96815004	SK-N-SH	brain:	n/a	chr2:96813968-96813982 chr2:96812145-96812161 chr2:96812146-96812162
22	POLR2A	chr2:96813968-96814764	H1-neurons	neurons:	n/a	n/a
23	PML	chr2:96806496-96814786	GM12878	blood:	n/a	chr2:96814389-96814398
24	POLR2A	chr2:96802923-96814679	GM12891	blood:	n/a	n/a
25	MAX	chr2:96814064-96815020	Hela-S3	cervix:	n/a	chr2:96814921-96814930 chr2:96814534-96814544
26	EP300	chr2:96813277-96815068	GM12878	blood:	n/a	chr2:96813968-96813982
27	EP300	chr2:96814032-96814716	GM12878	blood:	n/a	n/a
28	POLR2A	chr2:96814058-96814672	Hela-S3	cervix:	n/a	n/a
29	CHD2	chr2:96813401-96814920	GM12878	blood:	n/a	chr2:96814302-96814312
30	POLR2A	chr2:96797189-96814534	GM12892	blood:	n/a	n/a
31	RCOR1	chr2:96814031-96814697	Hela-S3	cervix:	n/a	n/a
32	MTA3	chr2:96806625-96815107	GM12878	blood:	n/a	n/a
33	CREB1	chr2:96813650-96815001	GM12878	blood:	n/a	n/a
34	POLR2A	chr2:96813696-96814516	GM12892	blood:	n/a	n/a
35	GATA3	chr2:96813831-96814751	SK-N-SH	brain:	n/a	chr2:96814316-96814324
36	POLR2A	chr2:96806534-96814566	GM12891	blood:	n/a	n/a
37	KAP1	chr2:96812525-96814932	HEK293	kidney:	n/a	chr2:96814389-96814398
38	BHLHE40	chr2:96813184-96814837	GM12878	blood:	n/a	n/a
39	POLR2A	chr2:96814047-96814325	MCF10A-Er-Src	breast:	n/a	n/a
40	CHD1	chr2:96813984-96814527	GM12878	blood:	n/a	chr2:96814302-96814312
41	POLR2A	chr2:96803003-96814644	GM12878	blood:	n/a	n/a
42	POLR2A	chr2:96813770-96814634	GM18505	blood:	n/a	n/a
43	NFIC	chr2:96813940-96814761	SK-N-SH	brain:	n/a	n/a
44	NFIC	chr2:96813903-96814806	GM12878	blood:	n/a	n/a
45	MAFK	chr2:96813967-96814555	IMR90	lung:	n/a	chr2:96814082-96814098 chr2:96814080-96814100 chr2:96814083-96814097 chr2:96814389-96814399
46	STAT5A	chr2:96814055-96814719	GM12878	blood:	n/a	n/a
47	POLR2A	chr2:96813065-96814773	Raji	blood:	n/a	n/a
48	BRCA1	chr2:96813979-96814742	Hela-S3	cervix:	n/a	n/a
49	POLR2A	chr2:96814070-96814656	Hela-S3	cervix:	n/a	n/a
50	MAZ	chr2:96814010-96814849	GM12878	blood:	n/a	chr2:96814534-96814544

No.	Distal block	Cell Line	Cell type
1	chr2:96813186..96815760-chr2:96873244..96875582,3	MCF-7	breast:
2	chr2:96781942..96784647-chr2:96809826..96814461,4	MCF-7	breast:
3	chr2:96812496..96814407-chr2:96931175..96932948,2	MCF-7	breast:
4	chr2:96808076..96814305-chr2:96871431..96875215,8	MCF-7	breast:
5	chr2:96812916..96814521-chr2:96834826..96836596,2	K562	blood:

Variant related genes	Relation type
ENSG00000228873	TF binding region
DUSP2	TF binding region
ENSG00000135956	Chromatin interaction
ENSG00000204685	Chromatin interaction
ENSG00000084090	Chromatin interaction
ENSG00000222040	Chromatin interaction
ENSG00000144021	Chromatin interaction

Extended variants
information (count: 67 )
Associated
traits (count: 8 )

rSNPs within LD-proxies of this variant (count:49)

rs_ID	r²[population]
rs10183151	0.95[CEU][hapmap];0.91[EUR][1000 genomes]
rs1030864	0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs11680950	0.95[CEU][hapmap];0.89[JPT][hapmap];1.00[YRI][hapmap]
rs1168965	0.95[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.80[YRI][hapmap];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs1168966	0.86[CEU][hapmap];0.83[EUR][1000 genomes]
rs1168967	0.83[EUR][1000 genomes]
rs1168968	1.00[CEU][hapmap];0.91[CHB][hapmap];0.90[JPT][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs1168970	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs1168972	0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs1168974	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs1168976	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs11693248	0.83[EUR][1000 genomes]
rs13019188	0.81[CEU][hapmap]
rs1657502	0.82[CEU][hapmap];0.80[EUR][1000 genomes]
rs1724121	0.85[EUR][1000 genomes]
rs1724125	0.93[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs2140938	0.84[EUR][1000 genomes]
rs2229169	0.95[CEU][hapmap];0.96[CHB][hapmap];0.90[JPT][hapmap];0.87[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2301707	1.00[CEU][hapmap]
rs2312955	0.90[CEU][hapmap];0.91[CHB][hapmap];0.95[JPT][hapmap];0.80[YRI][hapmap];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs2438978	0.81[CEU][hapmap];0.80[YRI][hapmap]
rs2462774	0.87[YRI][hapmap]
rs2576437	0.84[EUR][1000 genomes]
rs2579549	0.85[EUR][1000 genomes]
rs2579550	0.86[EUR][1000 genomes]
rs2579552	0.87[EUR][1000 genomes]
rs2692893	0.86[CEU][hapmap];0.82[CHB][hapmap];0.89[JPT][hapmap];0.89[EUR][1000 genomes]
rs2692894	0.95[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.87[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2692934	0.86[EUR][1000 genomes]
rs2692936	0.86[EUR][1000 genomes]
rs2692937	0.87[EUR][1000 genomes]
rs2917662	0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2969490	0.86[CEU][hapmap];0.84[EUR][1000 genomes]
rs2969491	0.95[CEU][hapmap];1.00[CHB][hapmap];0.84[JPT][hapmap];0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs3111873	0.86[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs3821051	1.00[CEU][hapmap];0.82[CHB][hapmap];0.84[JPT][hapmap];1.00[YRI][hapmap];0.85[EUR][1000 genomes]
rs4144055	0.88[YRI][hapmap]
rs4426564	0.90[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.80[YRI][hapmap]
rs4907288	0.89[YRI][hapmap]
rs4907299	0.90[CEU][hapmap];0.90[EUR][1000 genomes]
rs58448550	0.83[EUR][1000 genomes]
rs6740563	0.89[YRI][hapmap]
rs749457	0.82[CEU][hapmap];0.83[EUR][1000 genomes]
rs749459	0.82[CEU][hapmap]
rs7561198	0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs7604842	0.95[CEU][hapmap];0.91[EUR][1000 genomes]
rs772175	1.00[CEU][hapmap];0.82[CHB][hapmap];0.90[JPT][hapmap];0.88[YRI][hapmap]
rs772178	1.00[CEU][hapmap];0.82[CHB][hapmap];0.90[JPT][hapmap];0.88[YRI][hapmap]
rs893173	0.82[CEU][hapmap];0.95[CHB][hapmap];0.89[JPT][hapmap];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:18 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv1840487	chr2:96582807-96836512	Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	48 gene(s)	inside rSNPs	diseases
2	nsv874673	chr2:96647856-96825363	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	46 gene(s)	inside rSNPs	diseases
3	esv1825266	chr2:96704118-96830753	Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	44 gene(s)	inside rSNPs	diseases
4	nsv1004129	chr2:96738585-96825363	Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
5	nsv933671	chr2:96739308-97652262	Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	156 gene(s)	inside rSNPs	diseases
6	nsv1000780	chr2:96740430-97671395	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	156 gene(s)	inside rSNPs	diseases
7	nsv535826	chr2:96740430-97671395	Enhancers Flanking Active TSS Strong transcription Weak transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	156 gene(s)	inside rSNPs	diseases
8	nsv874675	chr2:96741944-96825363	Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
9	nsv874676	chr2:96753149-96825363	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
10	esv1819594	chr2:96755038-96833480	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Weak transcription Active TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
11	nsv1008495	chr2:96755070-96825363	Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
12	nsv1002392	chr2:96756289-96815149	Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
13	nsv874677	chr2:96756547-97717345	Strong transcription Enhancers Flanking Active TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	162 gene(s)	inside rSNPs	diseases
14	nsv1004977	chr2:96757107-96819188	Active TSS Weak transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
15	nsv1015000	chr2:96757107-96825363	Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
16	nsv1001204	chr2:96766559-97728507	Enhancers Flanking Active TSS Weak transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	162 gene(s)	inside rSNPs	diseases
17	nsv535827	chr2:96766559-97728507	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	162 gene(s)	inside rSNPs	diseases
18	nsv1007132	chr2:96767204-96829489	Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases

mRNA abundance (count:8)

SNP	Gene	Cis/trans	Tissue	Source
rs1168975	ADRA2B	cis	Nerve Tibial	GTEx
rs1168975	FAHD2CP	cis	lung	GTEx
rs1168975	AC008268.2	cis	Adipose Subcutaneous	GTEx
rs1168975	GPAT2	cis	Adipose Subcutaneous	GTEx
rs1168975	GPAT2	cis	Muscle Skeletal	GTEx
rs1168975	CIAO1	cis	Skin Sun Exposed Lower leg	GTEx
rs1168975	ADRA2B	cis	Thyroid	GTEx
rs1168975	FAHD2CP	cis	Muscle Skeletal	GTEx

Chromatin state (count:95 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:96810000-96815000	Enhancers	Fetal Heart	heart
2	chr2:96810400-96815000	Enhancers	Fetal Lung	lung
3	chr2:96811200-96814400	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
4	chr2:96811200-96814400	Weak transcription	Gastric	stomach
5	chr2:96811200-96814600	Enhancers	Spleen	Spleen
6	chr2:96811200-96814800	Enhancers	Lung	lung
7	chr2:96811200-96815000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr2:96811200-96815000	Enhancers	NH-A	brain
9	chr2:96811200-96815200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr2:96811400-96814200	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
11	chr2:96811400-96814200	Weak transcription	A549	lung
12	chr2:96811400-96814400	Enhancers	Right Atrium	heart
13	chr2:96811400-96814600	Enhancers	Osteobl	bone
14	chr2:96811400-96814800	Flanking Active TSS	Fetal Thymus	thymus
15	chr2:96811400-96815000	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
16	chr2:96811400-96815200	Flanking Active TSS	Hela-S3	cervix
17	chr2:96811600-96814200	Weak transcription	Pancreas	Pancrea
18	chr2:96811600-96814400	Enhancers	Skeletal Muscle Female	skeletal muscle
19	chr2:96811600-96814600	Enhancers	Left Ventricle	heart
20	chr2:96811600-96814600	Enhancers	Skeletal Muscle Male	skeletal muscle
21	chr2:96811600-96815000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr2:96811600-96815000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
23	chr2:96811600-96815000	Bivalent Enhancer	Fetal Muscle Leg	muscle
24	chr2:96811600-96815000	Enhancers	Right Ventricle	heart
25	chr2:96811600-96815000	Enhancers	HMEC	breast
26	chr2:96811600-96815200	Enhancers	Fetal Stomach	stomach
27	chr2:96811800-96814200	Enhancers	Colonic Mucosa	Colon
28	chr2:96811800-96814400	Enhancers	K562	blood
29	chr2:96811800-96814800	Enhancers	Adipose Nuclei	Adipose
30	chr2:96811800-96815000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
31	chr2:96811800-96815200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr2:96812200-96815000	Enhancers	Rectal Mucosa Donor 29	rectum
33	chr2:96812200-96815200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
34	chr2:96812400-96814200	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
35	chr2:96812400-96814200	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
36	chr2:96812400-96814400	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
37	chr2:96812400-96815000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
38	chr2:96812400-96815000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
39	chr2:96812400-96815000	Flanking Active TSS	Thymus	Thymus
40	chr2:96812400-96815200	Enhancers	Primary monocytes fromperipheralblood	blood
41	chr2:96812400-96815200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr2:96812400-96815400	Enhancers	Primary B cells from cord blood	blood
43	chr2:96812600-96814400	Enhancers	Primary B cells from peripheral blood	blood
44	chr2:96812600-96814400	Enhancers	Duodenum Mucosa	Duodenum
45	chr2:96812600-96815000	Enhancers	Primary hematopoietic stem cells short term culture	blood
46	chr2:96812600-96815000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr2:96812600-96815000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
48	chr2:96812600-96815200	Enhancers	NHEK	skin
49	chr2:96812600-96815400	Enhancers	Primary hematopoietic stem cells	blood
50	chr2:96812800-96814400	Enhancers	Sigmoid Colon	Sigmoid Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links